Literature DB >> 19077452

Update on the molecular pathogenesis of pancreatic tumors other than common ductal adenocarcinoma.

D Antonello1, S Gobbo, V Corbo, B Sipos, N R Lemoine, A Scarpa.   

Abstract

PURPOSE: Although ductal adenocarcinoma is the most common and well known pancreatic tumor type, other distinct epithelial neoplasms affecting the pancreas that show different symptoms, biological behaviors and outcomes are becoming more frequently recognized and documented. Pancreatic epithelial tumors may be separated into ductal and nonductal neoplasms. The former group includes pancreatic ductal adenocarcinoma, intraductal papillary-mucinous tumor, mucinous cystic tumor and serous cystic tumor. The latter group includes pancreatic endocrine tumor, pancreatic acinar cell carcinoma, pancreatoblastoma and solid-pseudopapillary tumor. The aim of this review is to summarize recently acquired knowledge regarding the molecular characterization of these uncommon pancreatic epithelial neoplasms. RECENT
FINDINGS: Molecular studies of uncommon pancreatic epithelial tumors suggest that the different morphological entities are associated with distinct molecular profiles, highlighting the involvement of different molecular pathways leading to the development of each subtype of pancreatic neoplasm.
CONCLUSION: The correct classification of rare pancreatic epithelial tumors and the identification of their characteristic molecular aspects is the fundamental starting point in identifying novel diagnostic molecular tools and new targets for innovative therapeutic strategies. Copyright 2008 S. Karger AG, Basel and IAP.

Entities:  

Mesh:

Year:  2008        PMID: 19077452     DOI: 10.1159/000178872

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  5 in total

1.  Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion.

Authors:  Tracy Layton; Cristel Stalens; Felizza Gunderson; Steve Goodison; Steve Silletti
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

2.  Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice.

Authors:  Run Yu; Deepti Dhall; Nicholas N Nissen; Cuiqi Zhou; Song-Guang Ren
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

Review 3.  Recent developments in imaging of pancreatic neuroendocrine tumors.

Authors:  Nikolaos Kartalis; Raffaella Maria Pozzi Mucelli; Anders Sundin
Journal:  Ann Gastroenterol       Date:  2015 Apr-Jun

Review 4.  Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment.

Authors:  Cynthia Ro; Wanxing Chai; Victoria E Yu; Run Yu
Journal:  Chin J Cancer       Date:  2012-12-14

Review 5.  Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies.

Authors:  Marina Ayres Pereira; Iok In Christine Chio
Journal:  Genes (Basel)       Date:  2019-12-19       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.